A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults.

Seftel, M D; Barnett, M J; Couban, S; Leber, B; Storring, J; Assaily, W; Fuerth, B; Christofides, A; Schuh, A C

Seftel, M D; Barnett, M J; Couban, S; Leber, B; Storring, J; Assaily, W; Fuerth, B; Christofides, A; Schuh, A C.

Afiliação

Seftel MD; Princess Margaret Hospital, Toronto, ON.
Barnett MJ; University of British Columbia, Vancouver, BC.
Couban S; Dalhousie University, Halifax, NS.
Leber B; McMaster University, Hamilton, ON.
Storring J; McGill University Health Centre, Montreal, QC.
Assaily W; New Evidence, Toronto, ON.
Fuerth B; New Evidence, Toronto, ON.
Christofides A; New Evidence, Toronto, ON.
Schuh AC; Princess Margaret Hospital, Toronto, ON.

Curr Oncol ; 21(5): 234-50, 2014 Oct.

Article em En | MEDLINE | ID: mdl-25302032

Palavras-chave

Acute promyelocytic leukemia; Trisenox; allogeneic transplantation; apl; arsenic trioxide; ato; autologous transplantation; first-line treatment; infusions; management; prophylaxis; supportive care; transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Revista: Curr Oncol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google